Literature DB >> 10567632

Primary pulmonary hypertension.

A J Peacock1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567632      PMCID: PMC1763750          DOI: 10.1136/thx.54.12.1107

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  71 in total

1.  Attenuated K+ channel gene transcription in primary pulmonary hypertension.

Authors:  X J Yuan; J Wang; M Juhaszova; S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

2.  Doppler echocardiographic evaluation of latent pulmonary hypertension by passive leg raising.

Authors:  M Ohashi; K Sato; S Suzuki; M Kinoshita; K Miyagawa; M Kojima; Y Dohi
Journal:  Coron Artery Dis       Date:  1997-10       Impact factor: 1.439

3.  An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.

Authors:  G Mikhail; J Gibbs; M Richardson; G Wright; A Khaghani; N Banner; M Yacoub
Journal:  Eur Heart J       Date:  1997-09       Impact factor: 29.983

4.  Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.

Authors:  S A Kharitonov; J B Cailes; C M Black; R M du Bois; P J Barnes
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

Authors:  V V McLaughlin; D E Genthner; M M Panella; S Rich
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

6.  Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.

Authors:  T W Higenbottam; A Y Butt; A T Dinh-Xaun; M Takao; G Cremona; S Akamine
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

7.  Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application.

Authors:  S Rich; E Dodin; V V McLaughlin
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

8.  Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging.

Authors:  A A Tardivon; E Mousseaux; F Brenot; J Bittoun; O Jolivet; E Bourroul; P Duroux
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

Review 9.  Pulmonary vascular disorders in portal hypertension.

Authors:  P Hervé; D Lebrec; F Brenot; G Simonneau; M Humbert; O Sitbon; P Duroux
Journal:  Eur Respir J       Date:  1998-05       Impact factor: 16.671

10.  Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.

Authors:  M Nootens; B Schrader; E Kaufmann; R Vestal; W Long; S Rich
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

View more
  10 in total

1.  Peripheral airway obstruction in primary pulmonary hypertension.

Authors:  F J Meyer; R Ewert; M M Hoeper; H Olschewski; J Behr; J Winkler; H Wilkens; C Breuer; W Kübler; M M Borst
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice.

Authors:  Yanli Song; John E Jones; Hideyuki Beppu; John F Keaney; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

Review 3.  Current management of primary pulmonary hypertension.

Authors:  E S Klings; H W Farber
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

5.  Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease.

Authors:  S Sirrs; J Irving; G McCauley; K Gin; B Munt; G Pastores; P Mistry
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

6.  Recent trends in pulmonary arterial hypertension.

Authors:  Rajagopalan Natarajan
Journal:  Lung India       Date:  2011-01

7.  Pulmonary hypertension in parenchymal lung disease.

Authors:  Iraklis Tsangaris; Georgios Tsaknis; Anastasia Anthi; Stylianos E Orfanos
Journal:  Pulm Med       Date:  2012-10-10

8.  New concepts in the invasive and non invasive evaluation of remodelling of the right ventricle and pulmonary vasculature in pulmonary arterial hypertension.

Authors:  Enric Domingo; Rio Aguilar; Manuel López-Meseguer; Gisela Teixidó; Manuel Vazquez; Antonio Roman
Journal:  Open Respir Med J       Date:  2009-03-12

Review 9.  Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry.

Authors:  David Warburton; Saverio Bellusci; Pierre-Marie Del Moral; Vesa Kaartinen; Matt Lee; Denise Tefft; Wei Shi
Journal:  Respir Res       Date:  2003-06-19

Review 10.  Pulmonary Arterial Hypertension in Hispanics.

Authors:  Raiko Diaz; Gustavo Ferrer
Journal:  Cureus       Date:  2019-10-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.